InvestorsHub Logo
Followers 130
Posts 14996
Boards Moderated 1
Alias Born 06/04/2018

Re: None

Tuesday, 06/18/2019 2:20:47 PM

Tuesday, June 18, 2019 2:20:47 PM

Post# of 253
News: $CATB Catabasis Pharmaceuticals to Present at Upcoming Symposium on Muscle-Bone Interaction in Duchenne Muscular Dystrophy and Parent Project Muscular Dystrophy 25th Annual Conference

Catabasis Pharmaceuticals, Inc. (NASDAQ:CATB), a clinical-stage biopharmaceutical company, today announced that it will present edasalonexent, a novel NF-kB inhibitor in Phase 3 development for the treatment of Duchenne muscular dystrophy (DMD), at two upcoming meetings: the Symposium on M...

Read the whole news https://marketwirenews.com/news-releases/catabasis-pharmaceuticals-to-present-at-upcoming-symposium-on-muscle-bone-interaction-in-duchenne-muscular-dystrophy-and-parent-project-muscular-dystrophy-25th-annual-conference-8373896.html